Cisplatin causes apoptosis of DRG neurons in vitro and in vivo that can be prevented by high dose NGF. Design of a neuronal rescue strategy for patients receiving cisplatin will be facilitated by knowledge of the mechanism by which cisplatin causes DRG death. Inhibition of the fas receptor/ ligand interaction prevents apoptosis in certain cancer cell lines treated with DNA damaging agents, including cisplatin. We demonstrated that killing curves from mice lacking a functional fas receptor and wild-type controls were not different over a wide range of therapeutically relevant concentrations. However, cisplatin treatment of DRG caused redistribution of cytosolic bax and mitochondrial release of cytochrome c. Bax redistribution was prevented by high dose NGF. This demonstrates for the first time that cisplatin does not signal for death via the fas pathway, but it does initiate the mitochondrial stress pathway in neurons and that NGF blocks death upstream of bax redistribution. © 2002 Elsevier Science (USA)
INTRODUCTION
Cisplatin is one of the first line treatments for metastatic testicular and ovarian cancer. It is also used for treatment of bladder cancer and small cell lung carcinoma. About 20% of patients are unable to complete a full course of cisplatin chemotherapy due to neurologic damage. The cells primarily affected are cochlear hair cells and dorsal root ganglion (DRG) neurons. Neurotoxicity depends on the cumulative dose, generally occurs in adult patients receiving 400 -700 mg/m 2 cisplatin, is usually irreversible, and may continue to progress for several months after discontinuation of treatment (Thompson et al., 1984; Grunberg et al., 1989) .
We have demonstrated that cisplatin causes apoptosis of DRG neurons in vitro and in vivo (Gill and Windebank, 1998) . In both the in vitro and in vivo system, the amount of neuronal death increases with increasing doses of cisplatin. High dose nerve growth factor (NGF) can rescue DRG neurons from cisplatininduced apoptosis. Cancer cells, such as the colon cancer cell line HT-29, which lack the NGF receptor, gp 140TrkA , are not protected by high dose NGF (Gill and Windebank, 1998).
There are four major pathways leading to apoptosis: the death receptor, mitochondrial stress, ceramide, and granzyme B pathways (McDonald and Windebank, 2000) . Ceramide signaling is not activated by cisplatin treatment of DRG (Gill and Windebank, 2000) and the granzyme pathway is not known to be active in neurons. The apoptotic mechanism of cisplatin neurotoxicity is not known.
The fas system has been implicated in some forms of neuronal death (Le-Niculescu et al., 1999; Martin-Villalba et al., 1999; Cheema et al., 1999; FelderhoffMueser et al., 2000; Matsushita et al., 2000; Rosenbaum et al., 2000) and cisplatin-mediated death of cancer cells (Muller et al., 1997; Muller et al., 1998; Moers et al., 1999) as well as a neuronal-like cell line (Fulda et al., 1997) . Based on this evidence, we hypothesized that fas might signal for cisplatin-induced apoptosis in DRG neurons. To investigate this hypothesis we utilized C57BL/6J mice homozygous for the LPR (lym- 
